26.11.2012 Views

Guidelines for ATC classification and DDD assignment - WHOCC

Guidelines for ATC classification and DDD assignment - WHOCC

Guidelines for ATC classification and DDD assignment - WHOCC

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

The <strong>DDD</strong> <strong>for</strong> scopolamine plaster is one plaster (i.e. 1 UD). This<br />

<strong>DDD</strong> is based on prophylaxis of motion sickness.<br />

<strong>DDD</strong>s <strong>for</strong> other substances classified in this group are based on<br />

antiemetic treatment.<br />

The parenteral <strong>DDD</strong> <strong>for</strong> aprepitant (expressed as fosaprepitant) is<br />

based on the avarage daily dose in a three days combined<br />

parenteral/oral course.<br />

A05 BILE AND LIVER THERAPY<br />

A05A BILE THERAPY<br />

A05AA Bile acid preparations<br />

Preparations classified in this group are primarily bile acid preparations,<br />

but various combinations, e.g. with spasmolytics, can also be included in<br />

each 5th level.<br />

A05AB Preparations <strong>for</strong> biliary tract therapy<br />

A05AX Other drugs <strong>for</strong> bile therapy<br />

This group comprises other drugs <strong>for</strong> bile therapy, which cannot be<br />

classified in the preceding groups.<br />

A05B LIVER THERAPY, LIPOTROPICS<br />

A05BA Liver therapy<br />

Tioctic acid is classified in A16AX.<br />

Preparations containing silibinin are classified at the same <strong>ATC</strong> 5th<br />

level as silymarin.<br />

A05C DRUGS FOR BILE THERAPY AND LIPOTROPICS IN<br />

COMBINATION<br />

61

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!